Literature DB >> 5652701

A new analytical procedure for dapsone. Application to blood-level and urinary-excretion studies in normal men.

A J Glazko, W A Dill, R G Montalbo, E L Holmes.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1968        PMID: 5652701

Source DB:  PubMed          Journal:  Am J Trop Med Hyg        ISSN: 0002-9637            Impact factor:   2.345


× No keyword cloud information.
  11 in total

1.  Falciparum malaria cured by quinine followed by sulfadoxine-pyrimethamine.

Authors:  A P Hall; E B Doberstyn; V Mettaprakong; P Sonkom
Journal:  Br Med J       Date:  1975-04-05

2.  Simultaneous analysis of dapsone and monoacetyldapsone employing high performance liquid chromatography: a rapid method for determination of acetylator phenotype.

Authors:  K Carr; J A Oates; A S Nies; R L Woosley
Journal:  Br J Clin Pharmacol       Date:  1978-11       Impact factor: 4.335

3.  Activity of subinhibitory concentrations of dapsone alone and in combination with cell-wall inhibitors against Mycobacterium avium complex organisms.

Authors:  N Rastogi; K S Goh; V Labrousse
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1993-12       Impact factor: 3.267

4.  Plasma and salivary pharmacokinetics of dapsone estimated by a thin layer chromatographic method.

Authors:  R A Ahmad; H J Rogers
Journal:  Eur J Clin Pharmacol       Date:  1980-02       Impact factor: 2.953

Review 5.  Clinical pharmacokinetics of dapsone.

Authors:  J Zuidema; E S Hilbers-Modderman; F W Merkus
Journal:  Clin Pharmacokinet       Date:  1986 Jul-Aug       Impact factor: 6.447

Review 6.  Clinical pharmacokinetic considerations in the treatment of patients with leprosy.

Authors:  K Venkatesan
Journal:  Clin Pharmacokinet       Date:  1989-06       Impact factor: 6.447

Review 7.  New prospects for the study of leprosy in the laboratory.

Authors:  R J Rees
Journal:  Bull World Health Organ       Date:  1969       Impact factor: 9.408

8.  A rapid method for determination of acetylation phenotype using dapsone.

Authors:  P A Philip; M S Roberts; H J Rogers
Journal:  Br J Clin Pharmacol       Date:  1984-04       Impact factor: 4.335

9.  Susceptibility of Mycobacterium leprae to dapsone as a determinant of patient response to acedapsone.

Authors:  L Levy; J H Peters
Journal:  Antimicrob Agents Chemother       Date:  1976-01       Impact factor: 5.191

10.  Pharmacokinetics and protein binding interactions of dapsone and pyrimethamine.

Authors:  R A Ahmad; H J Rogers
Journal:  Br J Clin Pharmacol       Date:  1980-11       Impact factor: 4.335

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.